Phytochemical Screening, GC-MS and FTIR analysis of Bioactive Compounds in Methanolic Leaf Extracts of Costus igneus (CIMLE) as a Natural Source of Drug Lead Molecules for Next-generation Drug-design, Development and Therapeutics

Abstract

Diabetes mellitus (DM) is a metabolic disorder that affects people of all ages. Increased prevalence of diabetes worldwide has led to the development of synthetic drugs to provide an interim solution to the ill effects of the issue. However, such drugs, although effective as antihyperglycemic agents, are accompanied by significant side effects, costly, and inaccessible to majority of people in remote in underdeveloped countries. Local medicinal plants have been used by such indigenous people through ages to treat such complicate ailments due to their ease of availability and GRAS nature. As diabetes continues to become prevalent, health care practitioners are considering PBNPs as a potential source of antidiabetic drugs due to their high potency and fewer side effects. To better understand the mechanism of action of medicinal plants, their active phytoconstituents are being isolated and investigated thoroughly. Phytochemical screening followed by GCMS analysis of methanolic leaf extracts of Costus igneus depicted the presence of 19 bioactive compounds viz., Bicyclo [3.1.1]heptane, 2,6,6- trimethyl-; 2-Pentadecanone, 6,10,14-trimethyl-; phthalic acid; 3,7,11,15-Tetramethyl-2-hexadecen- 1-ol; 5,9,13-Pentadecatrien-2-one, 6,10,14- trimethyl; 2(3H)-Furanone,dihydro-5-methyl-5- pentyl; Hexamethyl-2,6,10,14,18,22- tetracosahexaen-1-yl]-6-methox.; Oxalic acid, cyclohexyl isohexyl ester; 6-Octadecenoic acid; Phytol; 4,8,12,16-Tetramethylheptadecan-4- olide; 5-methyl-2,3-dihydro-1H-indole; Bis(2-ethylhexyl) phthalate; Adamantane-1-carboxylic acid methyl ester; Benzopyran-6-ol,3,4-dihydro-; Benzoquinoline; gamma-Tocopherol; dimethyl-5,5'-diphenyl-1H,; 1H-benzo[b]furo[2,3-f]indole that may be ADMET predicted for potential biomedical application in the treatment of diabetics and long term complications associated with the disease. 
 Keywords: Costus igneus; CIMLE; GCMS; Phytochemical Screening; Antidiabetic Leads; NDDT; Antidiabetic Medicinal Plant

Antioxidant activity study and GC-MS profiling of Camellia sinensis Linn

“…The chemical compound 2-Pentadecanone, 6,10,14-trimethyl is alternatively referred to as Hexahydrofarnesyl acetone, 6,10,14-Trimethyl-2-pentadecanone, 6,10,14-Trimethylpentadecan-2-one, or Perhydrofarnesyl acetone. The chemical in question is classified as an aliphatic ketone [ 71 , 72 ]. Specifically, it can be more accurately categorized as a fatty acid-ketone, as discussed by Prakasia and Nair (2015).…”

ADMET-Evaluation, Pharmacokinetics, Drug-likeness and Medicinal Chemistry of GCMS Identified Bioactive Compounds of Moringa oleifera Natural-Ripened-Dried Methanolic Pod Extract (MOMPE) as a Potential Source of Natural Drug Frontrunner for Next Generation

“…Previous studies [38][39][40][41][42][43][44][45][46][47][48][49] indicates that the successful exploitation of plant based natural products depends on the identification, isolation, purification and ADMET characterization followed by clinical trials before its launch in the market. Phytochemical screening and GCMS analysis revealed the presence of 12 compounds namely -7-Octadecyne…”

From Flora to Pharmaceuticals: 100 new additions to angiosperms of Gafargaon subdistrict in Bangladesh and unraveling antidiabetic drug candidates targeting DPP4 through in silico approach

“…This botanical gem boasts a plethora of bioactive phytochemicals, presenting a promising avenue for the discovery and development of novel antidiabetic drug candidates. Forty-one compounds of C. cuspidatus were downloaded from the PubChem database (https://pubchem.ncbi.nlm.nih.gov) after extensive literature survey [34][35][36]. Alogliptin, a promising DPP4 inhibitor was used as the control drug and fetched from PubChem [37].…”